Physician

Amena Iqbal

According to 2025 Medicare claims, Amena Iqbal (NPI: 1124469523) practices endocrinology in the Niles, MI market, with the plurality of this provider's patient population coming from Berrien, MI. This provider's primary affiliated billing organization is LAKELAND MEDICAL PRACTICES (NPI: 1538397120; TIN: 270381199) and primary practice location at 49085-9159. Iqbal is affiliated with the West Michigan Accountable Care Organization, LLC (ACO ID: A4626), participating under the MSSP model.

Iqbal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 267 traditional Medicare patients, billed 943 HCPCS/CPT codes, and received $60,690 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 6,019 prescription claims across 590 beneficiaries totaling $3,078,562 in drug costs, led by Mounjaro (Tirzepatide). DME data shows 364 claims. Open Payments data shows 44 records totaling $732. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $9,460 to $60,690. Similarly, Part D prescription costs have moved sharply higher in recent years, from $2,667 to $3,078,562. For DME billing, reported payments moved sharply higher in recent years, from $5,070 to $136,936.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	55	87	$9,460
2019	189	531	$32,749
2020	228	623	$35,236
2021	246	737	$51,752
2022	236	674	$41,110
2023	281	921	$58,993
2024	267	943	$60,690

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	19	66	$2,667
2016	N/R	26	$378
2017	N/R	N/R	N/R
2018	22	29	$6,427
2019	191	918	$361,045
2020	276	1,554	$604,621
2021	318	2,617	$1,242,834
2022	358	3,224	$1,626,270
2023	459	3,647	$1,991,194
2024	590	6,019	$3,078,562

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	39	$4,462
2020	31	148	$26,263
2021	29	257	$49,083
2022	57	445	$79,169
2023	76	427	$77,628
2024	78	364	$144,778

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	95	184	$120
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	57	57	$88
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	211	325	$79
95251	Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report	98	232	$24
83036	Hemoglobin a1c level	70	93	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mounjaro	Tirzepatide	697	22,442	$813,247
Ozempic	Semaglutide	353	12,770	$415,778
Jardiance	Empagliflozin	298	15,215	$289,934
Humalog Kwikpen U-200	Insulin Lispro	113	5,300	$221,215
Humulin R U-500 Kwikpen	Insulin Regular, Human	81	2,584	$150,278

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	67	258	$121,951
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	N	N/R	13	$7,876
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	N/R	27	$6,013
E0784	External ambulatory infusion pump, insulin	Y	N/R	12	$3,927
E2103	Non-adjunctive, non-implanted continuous glucose monitor or receiver	N	11	11	$2,488

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	44	$732	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amena Iqbal?

Tedicare shows public-source Medicare data for Amena Iqbal (NPI 1124469523), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amena Iqbal have ACO affiliation data?

Amena Iqbal is shown with ACO affiliation data for West Michigan Accountable Care Organization, LLC (MSSP, ACO ID A4626).

What billing organization is linked to Amena Iqbal?

Amena Iqbal is linked to LAKELAND MEDICAL PRACTICES (billing NPI 1538397120) in the available physician profile data.

Does Amena Iqbal have Open Payments data?

Amena Iqbal has 44 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.